Merck Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation

• Four graduate student chemists awarded for innovation in synthetic organic chemistry
• Tim Gatzenmeier, Max-Planck-Institut für Kohlenforschung, selected for grand prize

Darmstadt, Germany, October 2, 2018 — Merck, the vibrant science and technology company, recognized four graduate students for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium in Darmstadt, Germany, on September 27. Students presented their research to an audience of Merck staff and guests and a panel of judges selected Tim Gatzenmeier from the Max-Planck-Institut für Kohlenforschung, Mulheim, Germany, for the $3,000 grand prize based on his research in asymmetric enantioselective organocatalysis.

“As a longstanding leader and collaborator in the chemistry space, Merck always looks forward to learning from and acknowledging the research of these young scientists,” said Udit Batra, member of the Merck Executive Board CEO, Life Science. “What is especially exciting is witnessing collaborative problem solving and curiosity in action that are driving discoveries around the world.”

Winners of $1,000 prizes were:

• Gabriel Lovinger; Boston College, USA, Conjunctive Cross-Coupling: Development and Exploration of New Reactions
• Jacob Ludwig; University of Michigan, USA, Catalytic Carbonyl Olefin Metathesis
• Hiroki Sato; University of Texas at Austin, USA, Development of new cycloaddition reactions of diols and their applications: bridge between synthetic chemistry and material science

This year’s finalists presented projects about synthetic methodologies and reactions for organic synthesis, a field ultimately focused on the creation of synthetic molecules for new drugs, performance materials and agricultural products.

The Alfred R. Bader Award for Student Innovation competition was open to advanced graduate students in synthetic organic chemistry from around the world and recognizes young chemists whose work is expected to accelerate progress in chemistry. The contest theme this year was the development of instrumentation broadly applicable to synthetic organic chemistry and the reactive use of current reagents, catalysts and ligands in methodology or total synthesis projects. The award is named for Sigma-Aldrich co-founder Alfred R. Bader.

For more than a decade, Merck has developed partnerships with academic chemists and their students in recognition of innovative chemistry through philanthropic contributions to the field.

Follow Merck on Twitter @Merckgroup, on Facebook @merckgroup and on LinkedIn.

メルクについて
Merck（メルク）はヘルスケア、ライフサイエンス、パフォーマンスマテリアルズの分野における世界有数のサイエンスとテクノロジー企業です。がんや多発性硬化症のためのバイオ医薬品を用いた治療法から、科学研究と生産に関する最先端システム、スマートフォンや液晶テレビ向けの液晶材料にいたるまで、約53,000人の従業員が人々の暮らしをより良くする技術の一層の進歩を目指しています。2017年は66カ国で153億ユーロの売上高を計上しました。

メルクは1668年に創業された世界で最も歴史の長い医薬・化学品会社で、 創業家が今でも、上場企業が率いるメルクグループの株式の過半数を所有しています。メルクの名称およびブランドのグローバルな権利は、メルクが保有しています。唯一の例外は米国とカナダで、両国ではEMDセローノ、ミリポアシグマ、EMDパフォーマンスマテリアルズとして事業を行っています。